XON $5.69 0.19 (3.2%)XON ProfileXON trades on the NASDAQ. MEMBERSHIP--
SECTOR
Health Care
INDUSTRY
Biotech & Pharma
MARKET CAPITALIZATION
$960 Million
Intrexon is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
XON Earnings
EPS
-0.35
P/E
--
Q2 Earnings for Apr, May & Jun
Thu, Aug 8, 2019
Since Earnings Report
XON -24.0%
Q3 Earnings for Jul, Aug & Sep
Tue, Nov 12, 2019Since Earnings ReportXON +2.9%XON Dividend
Dividend Yield
0.00%
Dividend Rate
$0.00
Ex-Dividend Date
--
Dividend Pay Date
--
Dividend Frequency
--
Dividend Payments
--XON Charts
52WL
$3.95
52WH
$9.10
All-Time
$68.78
![]() ![]() ![]() ![]() |
XON Industry CompetitorsBIOTECH & PHARMA |
Johnson & Johnson
![]() |
Merck
![]() |
Pfizer
![]() |
Bristol-Myers Squibb
![]() |
Amgen
![]() |
Novo Nordisk A/S
![]() |
AbbVie
![]() |
Eli Lilly
![]() |
Sanofi SA (ADR)
![]() |
Gilead Sciences
![]() |
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.